AQR Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,166
| Closed | -$397K | – | 2320 |
|
|
2023
Q1 | $397K | Buy |
17,166
+959
| +6% | +$22.2K | ﹤0.01% | 1849 |
|
|
2022
Q4 | $425K | Buy |
16,207
+2,294
| +16% | +$60.1K | ﹤0.01% | 1866 |
|
|
2022
Q3 | $274K | Buy |
+13,913
| New | +$274K | ﹤0.01% | 1971 |
|
|
2019
Q4 | – | Sell |
-247,940
| Closed | -$1.31M | – | 2194 |
|
|
2019
Q3 | $1.31M | Buy |
247,940
+107,618
| +77% | +$570K | ﹤0.01% | 1438 |
|
|
2019
Q2 | $1.08M | Buy |
140,322
+60,515
| +76% | +$466K | ﹤0.01% | 1463 |
|
|
2019
Q1 | $1.59M | Buy |
+79,807
| New | +$1.59M | ﹤0.01% | 1403 |
|
|
2016
Q4 | – | Sell |
-3,784
| Closed | -$235K | – | 2295 |
|
|
2016
Q3 | $235K | Sell |
3,784
-10,729
| -74% | -$666K | ﹤0.01% | 2129 |
|
|
2016
Q2 | $821K | Buy |
+14,513
| New | +$821K | ﹤0.01% | 1687 |
|